• By The Financial District


If all goes well, the first doses of a safe and effective coronavirus vaccine will likely become available to some high-risk Americans in late December or early January, Dr. Anthony Fauci, the top US infectious diseases expert, said, Julie Steenhuysen reported for Reuters

Based on current projections from vaccine front-runners Moderna Inc. and  Pfizer Inc, Americans will likely know “sometime in December whether or not we have a safe and effective vaccine,” Fauci, director of the National Institute of Allergy and Infectious Diseases, said in a live chat on Twitter and Facebook. “The first interim look (at trial results) should be, we hope, within the next few weeks,” he said. Both companies started the final stage of clinical testing in late July with tens of thousands of people taking part in each trial. 

Moderna earlier said it was on track to deliver interim data from its large, late-stage trial next month. Pfizer, which was expected to announce interim data in October, is now unlikely to release data before November, probably after the Nov. 3 US presidential election. The data will then need to be reviewed by the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), which will make recommendations on who gets the first doses if the trials prove successful. Practically speaking, Fauci said, the first vaccine doses would likely be deployed to individuals deemed most in need “by the end of December or the beginning of January.” 

Fauci’s comments were part of a conversation with Dr. Francis Collins, director of the National Institutes of Health, who took questions from listeners. Even with an effective vaccine to protect against the virus, Fauci said it will take time to get back to something approaching normal as vaccine-induced immunity builds both nationally and globally. He said life will likely not get back to normal “until the end of 2021 at least.”